Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Qyuns Therapeutics Co., Ltd. Class H ( (HK:2509) ) just unveiled an update.
Qyuns Therapeutics Co., Ltd., a company incorporated in the People’s Republic of China, has announced the closure of its H shares register from December 16 to December 19, 2025, in preparation for an extraordinary general meeting (EGM) scheduled for December 19, 2025. This meeting will allow shareholders whose names appear on the register by December 15, 2025, to attend and vote, indicating a significant event for stakeholder engagement and corporate governance.
The most recent analyst rating on (HK:2509) stock is a Hold with a HK$22.00 price target. To see the full list of analyst forecasts on Qyuns Therapeutics Co., Ltd. Class H stock, see the HK:2509 Stock Forecast page.
More about Qyuns Therapeutics Co., Ltd. Class H
Average Trading Volume: 798,714
Technical Sentiment Signal: Buy
Current Market Cap: HK$5.11B
See more data about 2509 stock on TipRanks’ Stock Analysis page.